New Launch24 Apr 2025, 05:43 pm
Morepen Laboratories Launches Four New Products, Reinforcing Commitment to Innovation and Accessible Healthcare
AI Summary
Morepen Laboratories, a leading pharmaceutical company, has announced the launch of four new products - Ticapen, UdoFix, LycoMore, and Acifix. The new launches cater to the domestic market and address critical needs in cardiology, hepatology, nutrition, and diabetology. This strategic expansion reinforces Morepen's commitment to scaling its finished dosages business while investing in cutting-edge R&D. The company is on track to reach a formulation business size of ₹ 1,000 crore over the next five years. The Indian pharmaceutical sector is poised to reach $130 billion by 2030, and Morepen is strongly positioned to play a leading role in this transformation.
Key Highlights
- Ticapen: A clinically proven, affordable antiplatelet therapy for ACS, Angina, and MI.
- UdoFix: A new benchmark in hepatoprotective therapy with 98.23% superior dissolution.
- LycoMore Syrup: Blends Lycopene, essential vitamins, and minerals to support immunity and recovery.
- Acifix Raft Suspension: Offers targeted relief for GERD, reflux, and heartburn with a unique paan flavor.